Cargando…
IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288755/ http://dx.doi.org/10.1186/2051-1426-2-S3-P83 |